Johnson & Johnson has added another piece to the data behind its effort to move Tecvayli into earlier-line therapy for multiple myeloma, including the first relapse setting. In the MajesTEC-9 trial, ...

NOTICE: The project that is the subject of this report was approved by the Governing Board of the National Research Council, whose members are drawn from the councils of the National Academy of ...

Texas has long served as a proving ground for results-driven policy. In 2023, the Texas Legislature unanimously passed House Bill 8, a landmark reform that fundamentally reshaped how community ...

PHOENIX — Texas women's basketball was arguably the best team in Phoenix. Until it wasn't. This will be one long summer for the Texas Longhorns, who pulled a collective no-show in Friday night's ...

In order to improve care for people with multiple sclerosis (MS), we need to understand more about their disease. The way we measure the impact of MS on daily life has remained relatively unchanged ...